• head_banner_01

Europe style for 1-Carbethoxy-4-Piperidone - Semaglutide for Type 2 Diabetes – Gentolex

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

We've been committed to offering easy,time-saving and money-saving one-stop purchasing support of consumer for Empagliflozin, Uridine Pseudouridine, Titanium Acetate, We have ISO 9001 Certification and qualified this product .over 16 years experiences in manufacturing and designing, so our products featured with best quality and competitive price. Welcome cooperation with us!
Europe style for 1-Carbethoxy-4-Piperidone - Semaglutide for Type 2 Diabetes – Gentolex Detail:

Product Detail

Name  Semaglutide
CAS number  910463-68-2
Molecular formula  C187H291N45O59
Molecular weight  4113.57754
EINECS Number  203-405-2

Synonyms

Sermaglutide; Semaglutide fandachem; Semaglutide impurity; Sermaglutide USP/EP; semaglutide; Sermaglutide CAS 910463 68 2; Ozempic, 

Description

Semaglutide is a new generation of GLP-1 (glucagon-like peptide-1) analogs, and semaglutide is a long-acting dosage form developed based on the basic structure of liraglutide, which has a better effect in the treatment of type 2 diabetes. Novo Nordisk has completed 6 Phase IIIa studies of semaglutide injection, and submitted a new drug registration application for semaglutide weekly injection to the U.S. Food and Drug Administration (FDA) on December 5, 2016. A Marketing Authorization Application (MAA) was also submitted to the European Medicines Agency (EMA).

Compared with liraglutide, semaglutide has a longer aliphatic chain and increased hydrophobicity, but semaglutide is modified with a short chain of PEG, and its hydrophilicity is greatly enhanced. After PEG modification, it can not only bind closely to albumin, cover the enzymatic hydrolysis site of DPP-4, but also reduce renal excretion, prolong the biological half-life, and achieve the effect of long circulation.

Application

Semaglutide is a long-acting dosage form developed based on the basic structure of liraglutide, which is more effective in treating type 2 diabetes.

Bioactivity

Semaglutide (Rybelsus, Ozempic, NN9535, OG217SC, NNC0113-0217) is a long-acting glucagon-like peptide 1 (GLP-1) analog, an agonist of GLP-1receptor, with a potential type 2 Therapeutic efficacy of diabetes mellitus (T2DM).

Quality System

In general, quality system and assurance is in place covering all stage of production of the finished product. Adequate manufacturing and control operations are performed in compliance with the approved procedures/ specifications. Change control and Deviation handling system is in place, and necessary impact assessment and investigation were conducted. Proper procedures are in place to ensure quality of product prior to release into the market.


Product detail pictures:

Europe style for 1-Carbethoxy-4-Piperidone - Semaglutide for Type 2 Diabetes – Gentolex detail pictures

Europe style for 1-Carbethoxy-4-Piperidone - Semaglutide for Type 2 Diabetes – Gentolex detail pictures


Related Product Guide:

We have been commitment to supply the competitive price ,excellent products and solutions high-quality, at the same time as fast delivery for Europe style for 1-Carbethoxy-4-Piperidone - Semaglutide for Type 2 Diabetes – Gentolex , The product will supply to all over the world, such as: Kuala Lumpur, Senegal, UK, With a wide range, good quality, reasonable prices and stylish designs, our solutions are extensively used in beauty and other industries. Our solutions are widely recognized and trusted by users and can meet continuously changing economic and social needs.
  • The company can think what our think, the urgency of urgency to act in the interests of our position, can be said this is a responsible company, we had a happy cooperation!
    5 Stars By Dawn from Malaysia - 2018.11.02 11:11
    As a veteran of this industry, we can say that the company can be a leader in the industry, select them is right.
    5 Stars By Joyce from Zurich - 2018.09.16 11:31
    Write your message here and send it to us